SlideShare ist ein Scribd-Unternehmen logo
1 von 5
Downloaden Sie, um offline zu lesen
Council meeting 20 October 2010                                            10.10/C/04

Public business


Regulatory Standards Policy
Purpose
To consider and agree the regulatory standards policy


Recommendations

The Council is asked to agree:

i.      the regulatory standards policy set out in Appendix 1

1.0     Introduction

1.1     The Council discussed the development of a standards policy at its meeting in
        June.

1.2     It was agreed that in addition to beginning work on developing the
        comprehensive suite of standards, a standards policy should be developed.
        This is now attached at Appendix 1.

1.3     The Council has previously seen a standards development timetable which is
        currently being reviewed.

2.0     Key Considerations

2.1     It is important that the standards policy sets out our approach to developing,
        publishing, monitoring and reviewing our standards and related supplementary
        guidance.

2.2     The policy should clearly set out the principles that apply when developing
        standards. These principles must be applied to any standards we develop and




10.10/C/04                                                                    Page 1 of 5
Regulatory Standards Policy                                          Council 20 October 2010


        publish.

2.3     The policy also sets out how our standards should be used by pharmacy
        professionals in their day to day practice and the status of the standards.

3.0     Equality and diversity implications

3.1     Standards development has equality and diversity implications.

3.2     Engagement with key parties will ensure that equality and diversity implications
        are identified and these will then need to be considered and taken account of
        hen developing our standards. Our standards must comply with our equality
        scheme.

4.0     Communications implications

4.1     To be effective our standards will require detailed engagement with our
        stakeholders.

4.2     We will need to promote all our standards and guidance to key interested
        parties.

4.3     Engagement with both pharmacy professionals and those who engage with or
        affected by pharmacy practice will be key to informing the review of our
        standards.

5.0     Resource implications

5.1     Our core requirements to engage and consult on our standards can be met
        within our existing budget.

5.2     Additional resource may be required to use innovative and new ways of
        engagement.

6.0     Risk implications

6.1     Council has a statutory duty to set standards and to consult on proposed
        standards. There is a risk to public health and safety and to the reputation of the
        GPhC if the development, implementation and review of standards is not done
        in an appropriate way.




Page 2 of 5                                                                       10.10/C/04
Regulatory Standards Policy                                      Council 20 October 2010


Recommendations

The Council is asked to agree:

i.       the regulatory standards policy set out in Appendix 1




Hugh Simpson, Director of Policy and Communications
General Pharmaceutical Council
hugh.simpson@pharmacyregulation.org , tel 020 3365 3503

 20 October 2010




10.10/C/04                                                                   Page 3 of 5
Regulatory Standards Policy                                               Council 20 October 2010


                                                                                    Appendix 1



 Regulatory Standards Policy
1.0     Introduction

1.1     We are responsible for setting standards that ensure the safe and effective practice of
        pharmacy. We are also responsible for setting the education and training standards for
        pharmacy professionals.

1.2     Our standards form an integral part of our regulatory framework.

2.0     Purpose of policy

2.1     The Pharmacy Order 2010 details the standards that we need to set.

2.2     This policy sets out our approach to developing, publishing, monitoring and reviewing
        our standards and related guidance. It also sets out the status of these documents, and
        the way in which these standards should be used by pharmacy professionals.

3.0     Policy statement

        Principles
3.1     Our standards must:
            secure the safe and effective practice of pharmacy in Great Britain;
            define the core requirements for all pharmacy professionals
            remain relevant and up-to-date
            be outcome focussed and support the development of innovative practice
            inform patients, the public, pharmacy professionals and pharmacy owners about
               the standards they can expect from pharmacy professionals and registered
               pharmacy premises.

        Development
3.2     We will develop our standards through collaboration with all key interest groups, both
        from the pharmacy professions and those who engage with or affected by pharmacy
        practice. They will be subject to full consultation and appropriate models of
        engagement .

3.3     Where appropriate, we will issue guidance to support the understanding and
        implementation of our standards. This guidance will explain how pharmacy
        professionals can meet the standards set by us.

3.4     We recognise that there may be more than one way in which a pharmacy professional
        can meet the standards. Therefore, a pharmacy professional whose practice diverges
        from the guidance will need to be able to demonstrate the reasons for this and that
        there was no negative impact on patient safety or undermining of confidence in the
        profession.

3.5     We recognise that other organisations, such as professional leadership bodies, trade
        associations, defence organisations and other agencies may also issue guidance.
        Pharmacy professionals should consider the availability of such guidance, particularly




 Page 4 of 5                                                                           10.10/C/04
Regulatory Standards Policy                                              Council 20 October 2010


        about detailed practice and use it to inform decision making where appropriate.

        Publishing
3.6     The standards for conduct, ethics and performance and continuing professional
        development have been issued and area available to all pharmacy professionals.

3.7     All guidance documents that we produce are published on our website.

        Monitoring
3.8     A pharmacy professional’s conduct will be judged against the standards. As a regulator
        our primary concern is a registrant’s fitness to practise and maintaining confidence in
        the professions. The standards, and any relevant supplementary guidance, will be
        central to any decision about whether we need to take any regulatory action.

3.9     Pharmacy professionals must use their professional judgement when deciding on a
        course of action and should use our standards and relevant supplementary guidance
        as a basis for making those decisions.

3.10    We will monitor our standards using a variety of methods. We will work with colleagues,
        for example the inspectorate and fitness to practise teams, to ensure our standards
        remain relevant, appropriate to current practice, accessible and fully understood by the
        professions. We will also continue to develop relationships with external stakeholders,
        including pharmacy professionals, patients and the public and others to generate
        continuous feedback on our standards.


4.0     Application of policy

4.1     The Director of Policy and Communications is responsible for the application of this
        policy.

5.0     Measurement and evaluation

5.1     The standards will be reviewed annually as part of the review of the standards
        development framework. We will consider a range of evaluation methods including
        quantitative and qualitative research.



 [Insert author, title, department]
 Reference:      [To be allocated when the policy is approved]
 Effective date: [Insert date]
 Review date: [Insert date




 10.10/C/04                                                                            Page 5 of 5

Weitere ähnliche Inhalte

Ähnlich wie 10.10 c04 regulatory standard

The Health and Social Care Act 2008
The Health and Social Care Act 2008The Health and Social Care Act 2008
The Health and Social Care Act 2008Nick .
 
WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management PostgradoMLCC
 
hod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxhod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxGeletaGalataa
 
0612 co1 summary report on modernising
0612 co1 summary report on modernising0612 co1 summary report on modernising
0612 co1 summary report on modernisingJames Andrews
 
Professional Standards for Occupational Therapy Practice, Conduct and Ethics.pdf
Professional Standards for Occupational Therapy Practice, Conduct and Ethics.pdfProfessional Standards for Occupational Therapy Practice, Conduct and Ethics.pdf
Professional Standards for Occupational Therapy Practice, Conduct and Ethics.pdfRebecca Ferriday
 
Pharmacy Services MSQH Survey Checklist.pdf
Pharmacy Services MSQH Survey Checklist.pdfPharmacy Services MSQH Survey Checklist.pdf
Pharmacy Services MSQH Survey Checklist.pdfsuhaime4
 
New standards for registered pharmacies – sept 2012
New standards for registered pharmacies – sept 2012New standards for registered pharmacies – sept 2012
New standards for registered pharmacies – sept 2012GPhC
 
Part - II Policy Formulation for CDA R11
Part - II Policy Formulation for CDA R11Part - II Policy Formulation for CDA R11
Part - II Policy Formulation for CDA R11jo bitonio
 
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...JRamniwas
 
Assessment Workbook TLIP5004 Develop a transport and logistics .docx
Assessment Workbook TLIP5004 Develop a transport and logistics .docxAssessment Workbook TLIP5004 Develop a transport and logistics .docx
Assessment Workbook TLIP5004 Develop a transport and logistics .docxfestockton
 
MEA Code of Promo Practices.pdf
MEA Code of Promo Practices.pdfMEA Code of Promo Practices.pdf
MEA Code of Promo Practices.pdfDavidov1
 
HCR 210 Week 1 DQs.docx
HCR 210 Week 1 DQs.docxHCR 210 Week 1 DQs.docx
HCR 210 Week 1 DQs.docxstudywriters
 
Unit 5: Principles of Botulinum Toxin Use in Aesthetic Medicine
Unit 5: Principles of Botulinum Toxin Use in Aesthetic MedicineUnit 5: Principles of Botulinum Toxin Use in Aesthetic Medicine
Unit 5: Principles of Botulinum Toxin Use in Aesthetic MedicineThe QCCP
 
Ch 5. ethical codes and ch 6. standards of practice for pharmacists
Ch 5. ethical codes and ch 6. standards of practice for pharmacistsCh 5. ethical codes and ch 6. standards of practice for pharmacists
Ch 5. ethical codes and ch 6. standards of practice for pharmacistsUniversity of Gondar
 

Ähnlich wie 10.10 c04 regulatory standard (20)

The Health and Social Care Act 2008
The Health and Social Care Act 2008The Health and Social Care Act 2008
The Health and Social Care Act 2008
 
WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management
 
hod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxhod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptx
 
NABH Dental Standards
NABH Dental Standards NABH Dental Standards
NABH Dental Standards
 
0612 co1 summary report on modernising
0612 co1 summary report on modernising0612 co1 summary report on modernising
0612 co1 summary report on modernising
 
Guidelines gdp
Guidelines gdpGuidelines gdp
Guidelines gdp
 
Professional Standards for Occupational Therapy Practice, Conduct and Ethics.pdf
Professional Standards for Occupational Therapy Practice, Conduct and Ethics.pdfProfessional Standards for Occupational Therapy Practice, Conduct and Ethics.pdf
Professional Standards for Occupational Therapy Practice, Conduct and Ethics.pdf
 
Pharmacy Services MSQH Survey Checklist.pdf
Pharmacy Services MSQH Survey Checklist.pdfPharmacy Services MSQH Survey Checklist.pdf
Pharmacy Services MSQH Survey Checklist.pdf
 
New standards for registered pharmacies – sept 2012
New standards for registered pharmacies – sept 2012New standards for registered pharmacies – sept 2012
New standards for registered pharmacies – sept 2012
 
Part - II Policy Formulation for CDA R11
Part - II Policy Formulation for CDA R11Part - II Policy Formulation for CDA R11
Part - II Policy Formulation for CDA R11
 
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
 
Assessment Workbook TLIP5004 Develop a transport and logistics .docx
Assessment Workbook TLIP5004 Develop a transport and logistics .docxAssessment Workbook TLIP5004 Develop a transport and logistics .docx
Assessment Workbook TLIP5004 Develop a transport and logistics .docx
 
MEA Code of Promo Practices.pdf
MEA Code of Promo Practices.pdfMEA Code of Promo Practices.pdf
MEA Code of Promo Practices.pdf
 
ISO 15189:2007
ISO 15189:2007ISO 15189:2007
ISO 15189:2007
 
INTRODUCTION TO NABH STANDARDS
INTRODUCTION  TO NABH STANDARDSINTRODUCTION  TO NABH STANDARDS
INTRODUCTION TO NABH STANDARDS
 
HCR 210 Week 1 DQs.docx
HCR 210 Week 1 DQs.docxHCR 210 Week 1 DQs.docx
HCR 210 Week 1 DQs.docx
 
Unit 5: Principles of Botulinum Toxin Use in Aesthetic Medicine
Unit 5: Principles of Botulinum Toxin Use in Aesthetic MedicineUnit 5: Principles of Botulinum Toxin Use in Aesthetic Medicine
Unit 5: Principles of Botulinum Toxin Use in Aesthetic Medicine
 
Sai pharma solutions inc scientific-regulatory affairs-quality management an...
Sai pharma solutions inc  scientific-regulatory affairs-quality management an...Sai pharma solutions inc  scientific-regulatory affairs-quality management an...
Sai pharma solutions inc scientific-regulatory affairs-quality management an...
 
Ch 5. ethical codes and ch 6. standards of practice for pharmacists
Ch 5. ethical codes and ch 6. standards of practice for pharmacistsCh 5. ethical codes and ch 6. standards of practice for pharmacists
Ch 5. ethical codes and ch 6. standards of practice for pharmacists
 
**Santa - Clinical Practice Guidelines We Can Trust
**Santa - Clinical Practice Guidelines We Can Trust**Santa - Clinical Practice Guidelines We Can Trust
**Santa - Clinical Practice Guidelines We Can Trust
 

Mehr von James Andrews

Practice to pharmacy referral form
Practice to pharmacy referral formPractice to pharmacy referral form
Practice to pharmacy referral formJames Andrews
 
Self selction of p medicines the journey
Self selction of p medicines the journeySelf selction of p medicines the journey
Self selction of p medicines the journeyJames Andrews
 
0612 c public session minutes confirmed
0612 c public session minutes   confirmed0612 c public session minutes   confirmed
0612 c public session minutes confirmedJames Andrews
 
Council workshop presentation june
Council workshop presentation   juneCouncil workshop presentation   june
Council workshop presentation juneJames Andrews
 
Background note for ad hoc group on med
Background note for ad hoc group on medBackground note for ad hoc group on med
Background note for ad hoc group on medJames Andrews
 
0112 co1 premises standards annex
0112 co1 premises standards annex0112 co1 premises standards annex
0112 co1 premises standards annexJames Andrews
 
Novemer 2011 council meeting public
Novemer 2011 council meeting publicNovemer 2011 council meeting public
Novemer 2011 council meeting publicJames Andrews
 
101020 october 20 2010 council minutes
101020 october 20 2010 council minutes101020 october 20 2010 council minutes
101020 october 20 2010 council minutesJames Andrews
 
G ph c foi response 2012-070
G ph c foi response 2012-070G ph c foi response 2012-070
G ph c foi response 2012-070James Andrews
 

Mehr von James Andrews (9)

Practice to pharmacy referral form
Practice to pharmacy referral formPractice to pharmacy referral form
Practice to pharmacy referral form
 
Self selction of p medicines the journey
Self selction of p medicines the journeySelf selction of p medicines the journey
Self selction of p medicines the journey
 
0612 c public session minutes confirmed
0612 c public session minutes   confirmed0612 c public session minutes   confirmed
0612 c public session minutes confirmed
 
Council workshop presentation june
Council workshop presentation   juneCouncil workshop presentation   june
Council workshop presentation june
 
Background note for ad hoc group on med
Background note for ad hoc group on medBackground note for ad hoc group on med
Background note for ad hoc group on med
 
0112 co1 premises standards annex
0112 co1 premises standards annex0112 co1 premises standards annex
0112 co1 premises standards annex
 
Novemer 2011 council meeting public
Novemer 2011 council meeting publicNovemer 2011 council meeting public
Novemer 2011 council meeting public
 
101020 october 20 2010 council minutes
101020 october 20 2010 council minutes101020 october 20 2010 council minutes
101020 october 20 2010 council minutes
 
G ph c foi response 2012-070
G ph c foi response 2012-070G ph c foi response 2012-070
G ph c foi response 2012-070
 

10.10 c04 regulatory standard

  • 1. Council meeting 20 October 2010 10.10/C/04 Public business Regulatory Standards Policy Purpose To consider and agree the regulatory standards policy Recommendations The Council is asked to agree: i. the regulatory standards policy set out in Appendix 1 1.0 Introduction 1.1 The Council discussed the development of a standards policy at its meeting in June. 1.2 It was agreed that in addition to beginning work on developing the comprehensive suite of standards, a standards policy should be developed. This is now attached at Appendix 1. 1.3 The Council has previously seen a standards development timetable which is currently being reviewed. 2.0 Key Considerations 2.1 It is important that the standards policy sets out our approach to developing, publishing, monitoring and reviewing our standards and related supplementary guidance. 2.2 The policy should clearly set out the principles that apply when developing standards. These principles must be applied to any standards we develop and 10.10/C/04 Page 1 of 5
  • 2. Regulatory Standards Policy Council 20 October 2010 publish. 2.3 The policy also sets out how our standards should be used by pharmacy professionals in their day to day practice and the status of the standards. 3.0 Equality and diversity implications 3.1 Standards development has equality and diversity implications. 3.2 Engagement with key parties will ensure that equality and diversity implications are identified and these will then need to be considered and taken account of hen developing our standards. Our standards must comply with our equality scheme. 4.0 Communications implications 4.1 To be effective our standards will require detailed engagement with our stakeholders. 4.2 We will need to promote all our standards and guidance to key interested parties. 4.3 Engagement with both pharmacy professionals and those who engage with or affected by pharmacy practice will be key to informing the review of our standards. 5.0 Resource implications 5.1 Our core requirements to engage and consult on our standards can be met within our existing budget. 5.2 Additional resource may be required to use innovative and new ways of engagement. 6.0 Risk implications 6.1 Council has a statutory duty to set standards and to consult on proposed standards. There is a risk to public health and safety and to the reputation of the GPhC if the development, implementation and review of standards is not done in an appropriate way. Page 2 of 5 10.10/C/04
  • 3. Regulatory Standards Policy Council 20 October 2010 Recommendations The Council is asked to agree: i. the regulatory standards policy set out in Appendix 1 Hugh Simpson, Director of Policy and Communications General Pharmaceutical Council hugh.simpson@pharmacyregulation.org , tel 020 3365 3503 20 October 2010 10.10/C/04 Page 3 of 5
  • 4. Regulatory Standards Policy Council 20 October 2010 Appendix 1 Regulatory Standards Policy 1.0 Introduction 1.1 We are responsible for setting standards that ensure the safe and effective practice of pharmacy. We are also responsible for setting the education and training standards for pharmacy professionals. 1.2 Our standards form an integral part of our regulatory framework. 2.0 Purpose of policy 2.1 The Pharmacy Order 2010 details the standards that we need to set. 2.2 This policy sets out our approach to developing, publishing, monitoring and reviewing our standards and related guidance. It also sets out the status of these documents, and the way in which these standards should be used by pharmacy professionals. 3.0 Policy statement Principles 3.1 Our standards must:  secure the safe and effective practice of pharmacy in Great Britain;  define the core requirements for all pharmacy professionals  remain relevant and up-to-date  be outcome focussed and support the development of innovative practice  inform patients, the public, pharmacy professionals and pharmacy owners about the standards they can expect from pharmacy professionals and registered pharmacy premises. Development 3.2 We will develop our standards through collaboration with all key interest groups, both from the pharmacy professions and those who engage with or affected by pharmacy practice. They will be subject to full consultation and appropriate models of engagement . 3.3 Where appropriate, we will issue guidance to support the understanding and implementation of our standards. This guidance will explain how pharmacy professionals can meet the standards set by us. 3.4 We recognise that there may be more than one way in which a pharmacy professional can meet the standards. Therefore, a pharmacy professional whose practice diverges from the guidance will need to be able to demonstrate the reasons for this and that there was no negative impact on patient safety or undermining of confidence in the profession. 3.5 We recognise that other organisations, such as professional leadership bodies, trade associations, defence organisations and other agencies may also issue guidance. Pharmacy professionals should consider the availability of such guidance, particularly Page 4 of 5 10.10/C/04
  • 5. Regulatory Standards Policy Council 20 October 2010 about detailed practice and use it to inform decision making where appropriate. Publishing 3.6 The standards for conduct, ethics and performance and continuing professional development have been issued and area available to all pharmacy professionals. 3.7 All guidance documents that we produce are published on our website. Monitoring 3.8 A pharmacy professional’s conduct will be judged against the standards. As a regulator our primary concern is a registrant’s fitness to practise and maintaining confidence in the professions. The standards, and any relevant supplementary guidance, will be central to any decision about whether we need to take any regulatory action. 3.9 Pharmacy professionals must use their professional judgement when deciding on a course of action and should use our standards and relevant supplementary guidance as a basis for making those decisions. 3.10 We will monitor our standards using a variety of methods. We will work with colleagues, for example the inspectorate and fitness to practise teams, to ensure our standards remain relevant, appropriate to current practice, accessible and fully understood by the professions. We will also continue to develop relationships with external stakeholders, including pharmacy professionals, patients and the public and others to generate continuous feedback on our standards. 4.0 Application of policy 4.1 The Director of Policy and Communications is responsible for the application of this policy. 5.0 Measurement and evaluation 5.1 The standards will be reviewed annually as part of the review of the standards development framework. We will consider a range of evaluation methods including quantitative and qualitative research. [Insert author, title, department] Reference: [To be allocated when the policy is approved] Effective date: [Insert date] Review date: [Insert date 10.10/C/04 Page 5 of 5